Repare Therapeutics
RPTX
RPTX was delisted on the 27th of January, 2026.
76 hedge funds and large institutions have $438M invested in Repare Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 10 closing their positions.
1,522% more call options, than puts
Call options by funds: $13M | Put options by funds: $803K
15% more capital invested
Capital invested by funds: $379M → $438M (+$58.6M)
1.03% more ownership
Funds ownership: 85.1% → 86.13% (+1%)
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
3% less funds holding
Funds holding: 78 → 76 (-2)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$3.51M |
| 2 |
LGM
Logos Global Management
San Francisco,
California
|
+$3.1M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.26M |
| 4 |
CM
Caption Management
Oklahoma City,
Oklahoma
|
+$899K |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$758K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.1M |
| 2 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$1.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$988K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$914K |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$529K |
RPTX Hedge Fund Activity: Q3 2023 in Review
76 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Repare Therapeutics (RPTX) for Q3 2023, worth a combined $438M — up 15% from $379M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of RPTX and 9 opened new positions — a net loss of 1 holder — while 21 trimmed existing stakes and 23 added.
The largest buyer was Deep Track Capital, adding an estimated $3.51M. The largest seller was Millennium Management, cutting an estimated $1.1M.
- 76 institutional investors held Repare Therapeutics (RPTX) as of Q3 2023, down from 78 in Q2 2023.
- Funds reported $438M of Repare Therapeutics stock for Q3 2023, up 15% quarter-over-quarter.
- 9 funds opened new Repare Therapeutics positions in Q3 2023 and 10 closed out, a net change of -1 holder.
- The largest Repare Therapeutics buyer in Q3 2023 was Deep Track Capital, an estimated $3.51M added.
- The largest Repare Therapeutics seller in Q3 2023 was Millennium Management, an estimated $1.1M sold.
Based on aggregated 13F filings for Q3 2023.